-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ankyloglossia_disposition-comments.pdf
May 04, 2015 - Disposition of Comments Report for Treatments for Ankyloglossia and Ankyloglossia With Concomitant Lip-Tie
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Treatments for Ankyloglossia and Ankyloglossia With Concomitant Lip-Tie
Draft review available for public comme…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lung-cancer-nonsurgical-therapies_executive.pdf
June 01, 2013 - 1
Comparative Effectiveness Review
Number 112
Local Nonsurgical Therapies for Stage I
and Symptomatic Obstructive
Non–Small-Cell Lung Cancer
Executive Summary
Background
Non–small-cell lung cancer (NSCLC)
refers to any type of epithelial lung
cancer other than small-cell lung cancer.1
The disease arises f…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ear-infection_executive.pdf
May 01, 2013 - 1
Comparative Effectiveness Review
Number 101
Otitis Media With Effusion:
Comparative Effectiveness of Treatments
Executive Summary
Background
Definition of Otitis Media With
Effusion
Otitis media with effusion (OME) is
defined as a collection of fluid in the
middle ear without signs or symptoms
of acute…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism_surveillance.pdf
October 01, 2012 - CER # 26: Therapies for Children with Autism Spectrum
Disorders (ASDs)
Original release date: April, 2011
Surveillance Report, 1st Assessment: January, 2012
Surveillance Report, 2nd Assessment: October, 2012
Key Findings, 1st Assessment:
• For Key Question 1, conclusions regarding intensive early
interven…
-
digital.ahrq.gov/sites/default/files/docs/citation/europe-e-prescribing-report.pdf
February 01, 2011 - Electronic Prescribing in the United Kingdom and in the Netherlands
Electronic Prescribing in the United Kingdom
and in the Netherlands
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/observational-research-scores_research.pdf
May 01, 2012 - DEcIDE 33: Summary Variables in Observational Resesarch: Propensity Scores and Disease Risk Scores
Research from the Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) Network
May 2012
Effective Health Care Program
Research Reports
Number 33
Summary Variables in Observational Research:
Prop…
-
digital.ahrq.gov/sites/default/files/docs/AHRQ%20Transcript%208-27-10.pdf
June 16, 2021 - Welcome to today’s AHRQ webcast, the National Web-Based Teleconference on Health IT and Underserved Populations Health IT Adoption in Rural Clinical Settings
______________________________________________________________________________________
AHRQ Transcript 8-27-10.doc Page 1 of 31
TRANSCRIPT OF AUDIO FILE:
…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
March 01, 2024 - 5D=field_product_type%3Amethods_guide_chapter&sort_by=field_product_pub_date
41
Afterword
Recognized
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2021qdr-datasources.pdf
December 31, 2021 - approximately 1.6 million American Indian and Alaska Native (AI/AN)
people who belong to 567 federally recognized
-
cdsic.ahrq.gov/sites/default/files/2023-10/Final%20OO%20Patient%20Outcomes%20of%20PC%20CDS%20to%20AHRQ%2010.6.23.pdf
January 01, 2023 - For
example, to determine the extent to which patients
recognized their HF medications, the interviewer
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/overview/background/corebackgrnd.pdf
January 01, 2013 - Only 22 percent nationally responded “never
or sometimes” to this item.66
Feasibility is recognized
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2022qdr-datasources.pdf
December 01, 2022 - Targeted
Approximately 1.7 million American Indian and Alaska Native people who belong to 574
federally recognized
-
digital.ahrq.gov/sites/default/files/Final%20OO%20Patient%20Outcomes%20of%20PC%20CDS%20to%20AHRQ%2010.6.23.pdf
January 01, 2010 - For
example, to determine the extent to which patients
recognized their HF medications, the interviewer
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
January 01, 2016 - information.”11 The controller successfully brought subjects back to
the euglycemic range, and the APDS “recognized
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-immunotherapy-2010_executive.pdf
January 01, 2010 - by the World
Allergy Organization, cited the emerging clinical data on
sublingual immunotherapy, recognized
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
January 01, 2015 - Although
European costs are not recognized as a direct proxy for U.S. costs, they provide some sense
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-screening_disposition-comments.pdf
April 01, 2012 - Disposition of Comments for Screening for Glaucoma: Comparative Effectiveness
Source: http://www.effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and-
reports/?pageaction=displayproduct&productid=1026
Published Online: April 2012
Comparative Effectiveness Research Review Disposition of Co…
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/liquid-biopsy-topicrefinement.pdf
July 29, 2021 - Final Topic Refinement Document - Role of Liquid Biopsy in Detection and Management of Cancer in the Medicare Population
1
Final Topic Refinement Document
Role of Liquid Biopsy in Detection and Management of Cancer
in the Medicare Population
ID: MYOE58
Agency for Healthcare Research and Quality
Te…
-
www.ahrq.gov/sites/default/files/2025-03/smith-werner-carayon-report.pdf
January 01, 2025 - Final Progress Report: Engineering Safe Care Journeys for Vulnerable Older Adults
AHRQ Grant Final Progress Report
Grant Award Number: R18 HS026624
Project Title: Engineering Safe Care Journeys for Vulnerable Older Adults
Grantee Organization: University of Wisconsin – Madison
Project Period: September 30, 2018 –…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0123-fullreport.pdf
November 01, 2019 - High-Risk Deliveries at Facilities with Level 3 or Higher NICU Services on Campus
1
High-Risk Deliveries at Facilities with Level 3 or
Higher NICU Services on Campus
Section 1. Basic Measure Information
1.A. Measure Name
High-Risk Deliveries at Facilities with Level 3 or Higher NICU Services on Campus
1.B. Me…